This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Marta Lorinczi: Innovator in Viral Research
Introduction
Marta Lorinczi is a prominent inventor based in Galveston, Texas. She has made significant contributions to the field of viral research, particularly in the development of innovative vaccine technologies.
Latest Patents
Marta holds a patent for "Viral pseudo-capsids including assembly agonists and antagonists." This patent involves recombinant hepatitis C virus (HCV) capsid proteins that self-assemble into large spherical virus-like particle structures. These viral capsids include conformational antigenic epitopes, which can be utilized as vaccines to induce a cellular or humoral immune response. Additionally, the self-assembling capsid proteins may serve as elements in diagnostic immunoassay procedures for HCV infection. Marta's work in this area has the potential to advance vaccine development and improve diagnostic methods.
Career Highlights
Marta is affiliated with the University of Texas System, where she continues her research and innovation in viral sciences. Her work has garnered attention for its potential impact on public health and disease prevention.
Collaborations
Marta collaborates with notable colleagues, including Meghan Kunkel and Stanley J Watowich, who contribute to her research endeavors and enhance the scope of her projects.
Conclusion
Marta Lorinczi's innovative work in viral research exemplifies the importance of scientific advancements in healthcare. Her contributions to vaccine development and diagnostic methods are paving the way for future breakthroughs in the fight against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile